skip to Main Content

Metabolism-related liabilities of a potent histone deacetylase (HDAC) inhibitor and relevance of the route of administration on its metabolic fate.

Fonsi M, Fiore F, Jones P, Kinzel O, Laufer R, Rowley M, Monteagudo E. (2009)
Xenobiotica. 2009 Oct;39(10):722-37.

More info on PubMed.gov
Back To Top